eBioMedicine, 2026
Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap

Stinson S., Shadrin A., Rahman Z. et al.

Lipids in Health and Disease, 2026
Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study

Kim S., Jun H., Jo G. et al.

Journal for ImmunoTherapy of Cancer, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Sato Y., Kodama T., Maesaka K. et al.

Journal of the American Society of Nephrology, 2026
RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis

Ye L., Jiang Z., Wu Y. et al.

ESC Heart Failure, 2026
Plasma protein profiles in different heart failure phenotypes

Lind L., Delgado-Velandia M.

Journal of Periodontal Research, 2026
Proteomic Characterization of Grade II Furcation Defects: A Discovery‐Phase Study

Chatzopoulos G., Sakellari D., Kaklamanos E. et al.

Hypertension, 2026
Integrative Proteomic Profiling of Blood Pressure and Hypertension

Aggarwal M., Joehanes R., Huan T. et al.

Translational Psychiatry, 2026
Astrocyte-related proteins mediate the association of YWHAG with Alzheimer’s pathology and enhance its diagnostic value

Zhang Z., Huang P., Yang Y. et al.

Lipids in Health and Disease, 2026
Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans

Larsson A., Eriksson L., Eriksson M.

Journal of Investigative Dermatology, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls

Sacknovitz Y., Zhou M., Kent J. et al.

Clinical Rheumatology, 2026
Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma

Wang H., Yan H., Yang M. et al.

Cardiovascular Research, 2026
miR-146a-5p mediates atherogenic signalling from immune to vascular cells

Climent M., Zani S., Salvarani N. et al.

HemaSphere, 2026
Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

Diorio C., Myers R., Li Y. et al.

Metabolism, 2026
When the proteome meets the metabolome observational and Mendelian randomization analyses

Zheng R., Delgado-Velandia M., Ärnlöv J. et al.

CNS Neuroscience & Therapeutics, 2026
Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via CCR2 / NF ‐ κB ‐Mediated Blood–Brain Barrier Disruption

Huang R., Gao L., Dai Y. et al.

Open Forum Infectious Diseases, 2026
Proteomic Profile After Intervention With Eplerenone Among Persons With HIV

Murthy A., Kolossváry M., Walpert A. et al.

Pulmonology, 2026
Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study

He L., Liu C., Zhao H. et al.

Circulation: Genomic and Precision Medicine, 2026
Associations of the ICAM1 p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome

Aneja A., Culler K., Ding J. et al.

Frontiers in Immunology, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia

Wang J., Pan S., Xiong C. et al.

Clinical & Experimental Allergy, 2026
Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

Sun N., Pat Y., Babayev H. et al.